Abbott Laboratories Statistics

Total Valuation

LON:0Q15 has a market cap or net worth of GBP 173.83 billion. The enterprise value is 178.90 billion.

Market Cap	173.83B
Enterprise Value	178.90B

Important Dates

The last earnings date was Wednesday, April 16, 2025.

Earnings Date	Apr 16, 2025
Ex-Dividend Date	Apr 15, 2025

Share Statistics

Current Share Class	1.74B
Shares Outstanding	n/a
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.73B

Valuation Ratios

The trailing PE ratio is 16.70 and the forward PE ratio is 24.84.

PE Ratio	16.70
Forward PE	24.84
PS Ratio	5.30
PB Ratio	4.58
P/TBV Ratio	11.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.76, with an EV/FCF ratio of 34.72.

EV / Earnings	17.18
EV / Sales	5.58
EV / EBITDA	20.76
EV / EBIT	30.10
EV / FCF	34.72

Financial Position

The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.27.

Current Ratio	1.78
Quick Ratio	1.09
Debt / Equity	0.27
Debt / EBITDA	1.17
Debt / FCF	2.00
Interest Coverage	14.30

Financial Efficiency

Return on equity (ROE) is 30.65% and return on invested capital (ROIC) is 8.45%.

Return on Equity (ROE)	30.65%
Return on Assets (ROA)	6.38%
Return on Invested Capital (ROIC)	8.45%
Return on Capital Employed (ROCE)	11.47%
Revenue Per Employee	287,490
Profits Per Employee	91,324
Employee Count	114,000
Asset Turnover	0.55
Inventory Turnover	2.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.08% in the last 52 weeks. The beta is 0.66, so LON:0Q15's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	+28.08%
50-Day Moving Average	130.54
200-Day Moving Average	120.01
Relative Strength Index (RSI)	59.62
Average Volume (20 Days)	1,807

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.97

Income Statement

In the last 12 months, LON:0Q15 had revenue of GBP 32.77 billion and earned 10.41 billion in profits. Earnings per share was 5.96.

Revenue	32.77B
Gross Profit	18.35B
Operating Income	6.08B
Pretax Income	5.69B
Net Income	10.41B
EBITDA	8.53B
EBIT	6.08B
Earnings Per Share (EPS)	5.96

Full Income Statement

Balance Sheet

The company has 5.30 billion in cash and 10.29 billion in debt, giving a net cash position of -4.99 billion.

Cash & Cash Equivalents	5.30B
Total Debt	10.29B
Net Cash	-4.99B
Net Cash Per Share	n/a
Equity (Book Value)	37.98B
Book Value Per Share	21.71
Working Capital	7.86B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.93 billion and capital expenditures -1.77 billion, giving a free cash flow of 5.15 billion.

Operating Cash Flow	6.93B
Capital Expenditures	-1.77B
Free Cash Flow	5.15B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 55.99%, with operating and profit margins of 18.54% and 31.89%.

Gross Margin	55.99%
Operating Margin	18.54%
Pretax Margin	17.37%
Profit Margin	31.89%
EBITDA Margin	26.03%
EBIT Margin	18.54%
FCF Margin	15.72%

Dividends & Yields

This stock pays an annual dividend of 1.77, which amounts to a dividend yield of 1.32%.

Dividend Per Share	1.77
Dividend Yield	1.32%
Dividend Growth (YoY)	5.35%
Years of Dividend Growth	6
Payout Ratio	28.92%
Buyback Yield	0.06%
Shareholder Yield	1.38%
Earnings Yield	5.99%
FCF Yield	2.96%

Dividend Details

Stock Splits

The last stock split was on June 1, 1998. It was a forward split with a ratio of 2.

Last Split Date	Jun 1, 1998
Split Type	Forward
Split Ratio	2

Scores

LON:0Q15 has an Altman Z-Score of 5.49.

Altman Z-Score	5.49
Piotroski F-Score	n/a